Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 6.4% in the afternoon session after a major long-term study from France indicated that its COVID-19 vaccine was safe and effective.
Rough Draft Atlanta on MSN
CDC vaccine committee overturns decades-old hepatitis B recommendation for newborns
A Centers for Disease Control and Prevention committee voted to eliminate a recommendation that all newborn babies receive a ...
Cork Beo on MSN
Traffic disruptions expected as Cork city water outage to impact hundreds of Leesiders
Warning of more discolouration issues too ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback